Fabrication of Anti-glaucoma Nanofibers as Controlled-Release Inserts for Ophthalmic Delivery of Brimonidine Tartrate: In Vivo Evaluation in Caprine Eye
Purpose: Chronic ailments usually decrease the quality of life due to the requirement for repetitive administration of drugs. Glaucoma is a chronic eye disease occurred because of increased intraocular pressure (IOP). Controlled-release inserts can overcome this challenge by a gradual release of the...
Saved in:
| Main Authors: | Fariba Shaikhi Shoushtari, Mohammadshakib Naghshbandy, Leila Rezaei, Saba Mehrandish, Shahla Mirzaeei |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Tabriz University of Medical Sciences
2024-07-01
|
| Series: | Advanced Pharmaceutical Bulletin |
| Subjects: | |
| Online Access: | https://apb.tbzmed.ac.ir/PDF/apb-14-378.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Multicenter Randomized Double-Masked Study Comparing Preservative-free Brimonidine Tartrate Ophthalmic Solution 0.025% with LUMIFY® 0.025% for Ocular Redness in Adults
by: Melissa Toyos, et al.
Published: (2025-07-01) -
Brimonidine-Soluplus Nanomicelles: Preparation and in-vitro evaluation
by: Noor Al wiswasi, et al.
Published: (2025-03-01) -
Novel Uses of Brimonidine
by: Hikkalagutti. S. Kruthika, et al.
Published: (2024-07-01) -
Central Nervous System Depression After Topical Administration of Brimonidine Eye Drops to Induce Vomiting in a Cat
by: Dalhae Kim, et al.
Published: (2025-05-01) -
Effect of brimonidine on anterior-chamber angle in patients with narrow angles
by: Johanna Timoteo-Cervantes, MD, et al.
Published: (2011-12-01)